Calumet (CLMT) Just Gave Investors Something To Think About
Royal Purple, a key brand within Calumet (CLMT), has introduced a revamped motor oil lineup organized into three tiers for drivers and racers, with availability scheduled to begin in January 2027.
For investors watching Calumet, the share price at US$47.33 now reflects a mixed near term pattern, with a 1 day share price return of 1.28% but a 30 day share price return down 14.38%. At the same time, the 90 day gain of 17.56% and year to date share price return of 142.10% point to strong momentum, supported by a 1 year total shareholder return of 139.89% and a 3 year total shareholder return of 254.66%.
Scan beyond Calumet and this Royal Purple news by lining up other specialty energy and fuels players using our curated list of 19 high quality undiscovered gems.
After a sharp run over the past year and a pullback in recent weeks, Calumet now faces a simple question: Does the current US$47.33 entry already bake in the Royal Purple story or not?
Most Popular Narrative: 15% Undervalued
Calumet is framed as undervalued in the most widely followed valuation storyline, with a fair value of $55.80 set against the last close at $47.33, which puts the Royal Purple relaunch into a bigger, portfolio level context.
The MaxSAF 150 project is on track to start up in the first half of 2026, enabling Calumet to produce 120-150 million annual gallons of sustainable aviation fuel (SAF) at relatively low capital costs, capturing premiums of $1-$2/gallon over renewable diesel and tapping into surging mandated and voluntary SAF demand globally, which is likely to drive a material step-up in revenues and EBITDA margin expansion once operational.
See why 5 investors see Calumet as 15% undervalued.
Result: Fair Value of $55.80 (UNDERVALUED)
Still, the Calumet story can shift quickly if regulatory support for renewable fuels weakens or if high debt levels limit flexibility when conditions change.
Find out about the key risks to this Calumet narrative.
Next Steps
If this mix of strong returns and real uncertainty around Calumet leaves you on the fence, move quickly and ground your view in the underlying checks. To weigh both sides clearly, start with the full breakdown of 3 key rewards and 1 important warning sign.
Looking for more Calumet sized ideas?
Do not stop your research with Calumet. Use focused screeners to surface other opportunities that match your risk level, income needs, or value focus.
- Target resilient balance sheets and steadier financial profiles through our 30 resilient stocks with low risk scores so you are not relying on a single story.
- Hunt for pricing that looks appealing on quality fundamentals with the 35 high quality undervalued stocks before momentum or headlines catch up.
- Build a portfolio that works for you between updates from Calumet by filtering for a 4 dividend fortresses that prioritises income alongside business strength.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com